Promed Bioscience secures over €1 million growth financing led by KV Fund II

Promed Bioscience, a biotech company specializing in advanced collagen-based biomaterials for regenerative medicine, has successfully closed a €1.25 million growth financing round led by KV Fund II. Overall, the investment emphasises KVF II’s commitment to supporting pioneering Cypriot companies with global potential. This new capital injection will enable Promed to expand production capacity, scale its […]